TickerFacts.

Thermo Fisher Scientific Inc. (TMO): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2010-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2017-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$8.98B
Year ended 2017-12-31
+4.2%
3-year compound annual growth
+8.0%
5-year compound annual growth
2007-12-31: $5.08B2008-12-31: $5.30B2009-12-31: $5.16B2010-12-31: $5.26B2011-12-31: $5.73B2012-12-31: $6.10B2013-12-31: $6.31B2014-12-31: $7.93B2015-12-31: $7.58B2016-12-31: $8.21B2017-12-31: $8.98B$8.98B
2007-12-31 Cost of Revenue (USD) 2017-12-31
Period endedCost of RevenueChange YoYSource filing
2017-12-31$8.98B+9.3%2018-02-28, From 2017-01-01
2016-12-31$8.21B+8.3%2018-02-28, From 2016-01-01
2015-12-31$7.58B-4.4%2018-02-28, From 2015-01-01
2014-12-31$7.93B+25.8%2017-02-28, From 2014-01-01
2013-12-31$6.31B+3.4%2016-02-25, From 2013-01-01
2012-12-31$6.10B+6.4%2015-02-26, From 2012-01-01
2011-12-31$5.73B+8.9%2014-02-27, From 2011-01-01
2010-12-31$5.26Bn/c2013-02-27, From 2010-01-01
2009-12-31$5.16B-2.7%2012-02-29, From 2009-01-01
2008-12-31$5.30B+4.3%2011-02-24, From 2008-01-01
2007-12-31$5.08Bn/a2010-02-26, From 2007-01-01